Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD
Open Access
- 1 January 2017
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 64 (2) , 221-227
Abstract
Estrogen replacement therapy in Turner syndrome should theoretically mimic the physiology of healthy girls. The objective of this study was to describe final height and bone mineral density (BMD) in a group of 17 Turner syndrome patients (group E) who started their ethinyl estradiol therapy with an ultra-low dosage (1-5 ng/kg/day) from 9.8-13.7 years. The subjects in group E had been treated with GH 0.35 mg/kg/week since the average age of 7.4 years. The 30 subjects in group L, one of the historical groups, were given comparable doses of GH, and conjugated estrogen 0.3125 mg/week ∼0.3125 mg/day was initiated at 12.2-18.7 years. The subjects in group S, the other historical group, were 21 patients who experienced breast development and menarche spontaneously. Final height (height gain < 2 cm/year) in group E was 152.4 ± 3.4 cm and the standard deviation (SD) was 2.02 ± 0.62 for Turner syndrome. The final height in group L was 148.5 ± 3.0 cm with a SD of 1.30 ± 0.55, which was significantly different from the values for group E. The volumetric BMD of group S (0.290 ± 0.026 g/cm3) was significantly different from that of group L or E (0.262 or 0.262 g/cm3 as a mean, respectively). This is the first study of patients with Turner syndrome where estrogen was administered initially in an ultra-low dose and then increased gradually. Our estrogen therapy in group E produced good final height but not ideal BMD.Keywords
This publication has 25 references indexed in Scilit:
- Effects of Low-Dose Estrogen Replacement During Childhood on Pubertal Development and Gonadotropin Concentrations in Patients With Turner Syndrome: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical TrialThe Journal of Clinical Endocrinology & Metabolism, 2014
- Height Gain in Ullrich-Turner Syndrome after Early and Late Growth Hormone Treatment Start: Results from a Large Retrospective German Study and Potential Basis for an Individualized Treatment ApproachHormone Research in Paediatrics, 2013
- Adult height in girls with Turner syndrome treated from before 6 years of age with a fixed per kilogram GH doseEuropean Journal of Endocrinology, 2013
- Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study GroupThe Journal of Clinical Endocrinology & Metabolism, 2007
- Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2005
- Epidemiological, endocrine and metabolic features in Turner syndromeEuropean Journal of Endocrinology, 2004
- Turner's SyndromeNew England Journal of Medicine, 2004
- Final Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment in Three Dosages and Low Dose EstrogensThe Journal of Clinical Endocrinology & Metabolism, 2003
- Growth hormone therapy of Turner's syndrome: Beneficial effect on adult heightThe Journal of Pediatrics, 1998
- A SYNDROME OF INFANTILISM, CONGENITAL WEBBED NECK, AND CUBITUS VALGUS1Endocrinology, 1938